ONCOLYTICS Other Wednesday, October 14, 2026 +0.10 Neutral

Oncolytics Announces GOBLET Study Updates and Final PanCAN Grant Payment

Oncolytics announced the completion of GOBLET enrollment and expects the final payment from the Pancreatic Cancer Action Network in the fourth quarter. The company expects initial Cohort 5 results in the first half of 2027.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

START FREE — 10,000 calls/day, no key needed